- “FDA Approves Opioid Pain Reliever with Required Risk Reduction Plan” (FDA.gov)
- “Mylan Gets FDA Nod For Generic Version Of King Pharma’s Thyroid Drug Cytomel” (Press release issued by Mylan Inc., Trading Markets)
- “Medtronic Files Pre-Market Approval Application for FDA Approval of Deep Brain Stimulation for Treatment-Resistant Epilepsy” (press release issued by Medtronic, BusinessWire)
- “Sumavel(TM) DosePro(TM) (sumatriptan injection) Approved by FDA for Acute Migraine and Cluster Headache: First Product Featuring Novel DosePro Needle-Free Delivery System” (Press release issued by Zogenix, Inc., PRNewsWire)
- “Novartis bets on faster drugs sales growth” (Reuters)
- “Shire’s Gaucher drug gets FDA fast-track status” (Market Watch)
- “Ipsen Reveals Results Of Phase I And Phase IIa Clinical Studies For BIM23A760 Chimeric Compound” (RTT News)
- “Pharma Accused of Keeping Good Generics Down” (Pharmaceutical Executive)
- “Osteoporosis Drug May Save Lives By Strengthening Immune System” (Science Daily)
THE LATEST WORD
Top Industry Stories – July 16, 2009
Posted on July 16th, 2009 | by Rxmedyn | No Comments »Posted in Industry Stories
SUBSCRIBE-
Recent Posts
Archives
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
Careers | © 2009 Medical Dynamics